286 related articles for article (PubMed ID: 10443041)
1. New pharmacological directions for the treatment of overweight and obesity.
Van Gaal LF; Peiffer FW; De Leeuw IH
Acta Clin Belg; 1999 Jun; 54(3):141-6. PubMed ID: 10443041
[No Abstract] [Full Text] [Related]
2. [Obesity in adults].
Suter PM; Kolyvanos NU; Käser L; Vetter W
Praxis (Bern 1994); 2007 Oct; 96(42):1617-24; quiz 1625-6. PubMed ID: 17974121
[No Abstract] [Full Text] [Related]
3. [Pharmacotherapy of obesity].
Svendsen OL
Ugeskr Laeger; 2004 Oct; 166(43):3814-7. PubMed ID: 15544112
[No Abstract] [Full Text] [Related]
4. [Pharmacotherapy in the treatment of obesity].
Hamann A
MMW Fortschr Med; 2006 Mar; 148(9):36-8. PubMed ID: 16566392
[TBL] [Abstract][Full Text] [Related]
5. [Anti-obesity drugs: sibutramine and orlistat].
Sempere I Verdú E; Palop Larrea V; Hidalgo Mora JJ; Martínez-Mir I
Med Clin (Barc); 2002 Mar; 118(11):437; author reply 437-8. PubMed ID: 11943108
[No Abstract] [Full Text] [Related]
6. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
7. Orlistat for obesity.
Med Lett Drugs Ther; 1999 Jun; 41(1055):55-6. PubMed ID: 10436767
[No Abstract] [Full Text] [Related]
8. Obesity, cardiovascular risk and pharmacotherapy.
Ruilope LM; Garcia-Robles R; Moreno B
Blood Press; 2002; 11(5):260-2. PubMed ID: 12458647
[No Abstract] [Full Text] [Related]
9. [Drug treatment of obesity].
Svendsen OL; Toubro S; Breum L; Bruun JM; Astrup AV
Ugeskr Laeger; 2006 Jan; 168(2):163-7. PubMed ID: 16403342
[TBL] [Abstract][Full Text] [Related]
10. Long-term pharmacotherapy for obesity and overweight.
Padwal R; Li SK; Lau DC
Cochrane Database Syst Rev; 2003; (4):CD004094. PubMed ID: 14584004
[TBL] [Abstract][Full Text] [Related]
11. [New treatments for obesity].
Féry F; Watrin I
Rev Med Brux; 1999 Sep; 20(4):A381-5. PubMed ID: 10523928
[TBL] [Abstract][Full Text] [Related]
12. The effects of sibutramine and orlistat on the ultrasonographic findings, insulin resistance and liver enzyme levels in obese patients with non-alcoholic steatohepatitis.
Sabuncu T; Nazligul Y; Karaoglanoglu M; Ucar E; Kilic FB
Rom J Gastroenterol; 2003 Sep; 12(3):189-92. PubMed ID: 14502318
[TBL] [Abstract][Full Text] [Related]
13. Long-term pharmacotherapy for obesity and overweight.
Padwal R; Li SK; Lau DC
Cochrane Database Syst Rev; 2004; 2003(3):CD004094. PubMed ID: 15266516
[TBL] [Abstract][Full Text] [Related]
14. [New drugs for the treatment of obesity].
Mustajoki P
Duodecim; 1999; 115(20):2191, 2193-4. PubMed ID: 11973921
[No Abstract] [Full Text] [Related]
15. [Weight reduction. Antiobesity drug treatment in type-2 diabetics].
Verspohl EJ
Pharm Unserer Zeit; 2002; 31(3):300-7. PubMed ID: 12071127
[No Abstract] [Full Text] [Related]
16. Pharmacological therapy of obesity: past, present, and future.
Weigle DS
J Clin Endocrinol Metab; 2003 Jun; 88(6):2462-9. PubMed ID: 12788841
[No Abstract] [Full Text] [Related]
17. The effectiveness of pharmaceutical interventions for obesity: weight loss with orlistat and sibutramine in a United Kingdom population-based cohort.
Douglas IJ; Bhaskaran K; Batterham RL; Smeeth L
Br J Clin Pharmacol; 2015 Jun; 79(6):1020-7. PubMed ID: 25641659
[TBL] [Abstract][Full Text] [Related]
18. The new role of pharmacotherapy for weight reduction in obesity.
Fernstrom MH; Fernstrom JD
Int J Clin Pract; 2002 Nov; 56(9):683-6. PubMed ID: 12469983
[TBL] [Abstract][Full Text] [Related]
19. Obesity.
Finer N
Clin Med (Lond); 2003; 3(1):23-7. PubMed ID: 12617409
[No Abstract] [Full Text] [Related]
20. Prevention and management of obesity: pharmacology .
Finer N
Proc Nutr Soc; 2000 Aug; 59(3):413. PubMed ID: 10997657
[No Abstract] [Full Text] [Related]
[Next] [New Search]